MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$6,589M
Net Income
$1,276M
Net Profit Margin
19.37%
EPS
$3.3
Unit: Million (M) dollars
Revenue Breakdown
Medical
Traumaand Extremities
Endoscopy
Others
Revenue Breakdown
US
Non Us
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net sales
6,589
6,020
7,171
6,057
Cost of sales
2,091
2,210
2,543
2,205
Gross profit
4,498
3,810
4,628
3,852
Research, development and engineering expenses
434
413
401
410
Selling, general and administrative expenses
2,229
2,281
2,227
2,045
Amortization of intangible assets
175
180
189
189
Asset impairments
1
0
7
73
Total operating expenses
2,839
2,874
2,824
2,717
Operating income
1,659
936
1,804
1,135
Interest expense
141
148
607
-
Other income
46
62
508
-106
Earnings before income taxes
1,564
850
1,705
1,029
Income taxes
288
105
856
170
Net earnings
1,276
745
849
859
Basic EPS
3.32
1.95
2.22
2.25
Diluted EPS
3.3
1.93
2.197
2.22
Basic Average Shares
383,500,000
382,900,000
382,500,000
382,400,000
Diluted Average Shares
386,000,000
386,500,000
386,500,000
386,700,000
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Medical
$1,122M
(13.33%↑ Y/Y)
Endoscopy
$1,004M
(11.68%↑ Y/Y)
Instruments
$1,003M
(30.60%↑ Y/Y)
Neurovascular
$496M
(-0.40%↓ Y/Y)
Traumaand Extremities
$1,072M
(12.02%↑ Y/Y)
Ortho Tech
$717M
Knees
$693M
(8.28%↑ Y/Y)
Hips
$479M
(2.79%↑ Y/Y)
Spinal Implants
$3M
Med Surg And
Neurotechnology
$3,625M
(-3.87%↓ Y/Y)
Orthopaedics And Spine
$2,964M
(31.67%↑ Y/Y)
Net sales
$6,589M
(9.42%↑ Y/Y)
Gross profit
$4,498M
(17.10%↑ Y/Y)
Cost of sales
$2,091M
(-4.13%↓ Y/Y)
Operating income
$1,659M
(49.06%↑ Y/Y)
Other income
$46M
(147.42%↑ Y/Y)
Total operating
expenses
$2,839M
(4.07%↑ Y/Y)
Earnings before income
taxes
$1,564M
(53.94%↑ Y/Y)
Interest expense
$141M
Selling, general and
administrative expenses
$2,229M
(7.22%↑ Y/Y)
Research, development and
engineering expenses
$434M
(6.63%↑ Y/Y)
Amortization of intangible
assets
$175M
(-6.42%↓ Y/Y)
Asset impairments
$1M
(-98.18%↓ Y/Y)
Net earnings
$1,276M
(44.34%↑ Y/Y)
Income taxes
$288M
(118.18%↑ Y/Y)
Buy us a coffee
STRYKER CORP (SYK)
STRYKER CORP (SYK)